vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2024-4-61-68vtio-1797Research ArticleКлиническая трансплантологияClinical TransplantologyОсобенности этиологии, патогенеза и эпидемиологии почечно-клеточного рака трансплантированной почкиFeatures of the etiology, pathogenesis and epidemiology of renal cell carcinoma in kidney transplant recipientshttps://orcid.org/0000-0002-3108-0539ТрушкинР. Н.TrushkinR. N.

Москва

Moscow

uro52@mail.ruhttps://orcid.org/0000-0003-3462-8616ИсаевТ. К.IsaevT. K.

Москва

Moscow

dr.isaev@mail.ruСоколовА. А.SokolovA. A.

Соколов Александр Александрович

143083, Московская область, Одинцовский район, пос. Барвиха, д. 26, кв. 38

Тел. (985) 492-35-77

Alexander Sokolov

26/38, Barvikha settlement, Odintsovo district, 143083, Moscow Oblast

Phone: (985) 492-35-77

salexdoc@gmail.comГБУЗ города Москвы «Городская клиническая больница № 52 Департамента здравоохранения города Москвы»РоссияMunicipal Clinical Hospital No. 52Russian FederationФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента РФРоссияCentral Clinical Hospital with ClinicRussian Federation2024280820242646168Copyright © Трушкин Р.Н., Исаев Т.К., Соколов А.А., 20252025Трушкин Р.Н., Исаев Т.К., Соколов А.А.Trushkin R.N., Isaev T.K., Sokolov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1797

Почечно-клеточный рак трансплантированной почки представляет собой уникальное явление, поскольку возникает в донорской почке у реципиента, находящегося на иммуносупрессивной терапии, и имеет исключительные различия от аналогичного рака, возникающего в нативной почке. Учитывая относительную редкость, характерную специфику почечно-клеточного рака трансплантата, трудность для его диагностики и лечения, данный вид опухоли изучен менее полно, чем «стандартный» почечно-клеточный рак, но в условиях нарастающего количества трансплантаций и, соответственно, увеличения числа выявления данной патологии у реципиентов, актуальность его изучения значительно нарастает.

Renal cell carcinoma (RCC) in a kidney transplant is a rare condition as it occurs in the donor kidney of a recipient undergoing immunosuppressive therapy and differs exceptionally from a similar cancer that develops in the native kidney. Given the relative rarity, characteristic specificity of RCC in transplant recipients, and the difficulty in diagnosis and treatment, this type of tumor is less thoroughly studied than the «standard» RCC. However, as more transplants are performed and recipients are being detected with this pathology more frequently, the study of this tumor becomes significantly relevant.

трансплантированная почкапочечно-клеточный ракэтиологияпатогенезэпидемиологияkidney graftrenal cell carcinomaetiologypathogenesisepidemiologyReferencesTonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011 Oct; 11 (10): 2093–2109. doi: 10.1111/j.1600-6143.2011.03686.x. Epub 2011 Aug 30. PMID: 21883901.Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011 Oct; 11 (10): 2093–2109. doi: 10.1111/j.1600-6143.2011.03686.x. Epub 2011 Aug 30. PMID: 21883901.Андрусев АМ, Перегудова НГ, Шинкарев МБ, Томилина НА. Заместительная почечная терапия хронической болезни почек 5-й стадии в Российской Федерации 2016–2020 гг. Краткий отчет по данным Общероссийского регистра заместительной почечной терапии Российского диализного общества. Нефрология и диализ. 2022; 24 (4): 555–565.Andrusev AM, Peregudova NG, Shinkarev MB, Tomilina NA. Kidney replacement therapy for end Stage Kidney disease in Russian Federation, 2016–2020. Russian National Kidney Replacement Therapy Registry Report of Russian Public Organization of Nephrologists «Russian Dialysis Society». Nephrologу and Dialуsis. 2022; 24 (4): 555–565. [In Russ.]. doi: 10.28996/2618-98012022-4-555-565.Готье СВ. Хомяков СМ. Донорство и трансплантация органов в Российской Федерации в 2019 году. XII сообщение национального регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов. 2020; 22 (2): 8–34.Gautier SV, Khomyakov SM. Organ donation and transplantation in Russian Federation in 2019. 12th report of National Registry. Russian Journal of Transplantology and Artificial Organs. 2020; 22 (2): 8–34. [In Russ, English abstract]. doi: 10.15825/1995-1191-20202-8-34.Lai X, Zheng X, Mathew JM, Gallon L, Leventhal JR, Zhang ZJ. Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front Immunol. 2021 May 20; 12: 661643. doi: 10.3389/fimmu.2021.661643. eCollection 2021. PMID: 34093552.Lai X, Zheng X, Mathew JM, Gallon L, Leventhal JR, Zhang ZJ. Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front Immunol. 2021 May 20; 12: 661643. doi: 10.3389/fimmu.2021.661643. eCollection 2021. PMID: 34093552.Van Loon E, Senev A, Lerut E, Coemans M, Callemeyn J, Van Keer JM et al. Assessing the Complex Causes of Kidney. Transplantation. 2020 Dec; 104 (12): 2557– 2566. doi: 10.1097/TP.0000000000003192. PMID: 32091487.Van Loon E, Senev A, Lerut E, Coemans M, Callemeyn J, Van Keer JM et al. Assessing the Complex Causes of Kidney. Transplantation. 2020 Dec; 104 (12): 2557– 2566. doi: 10.1097/TP.0000000000003192. PMID: 32091487.Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Stewart DE et al. OPTN/SRTR 2013 Annual data report: Kidney. Am J Transplant. 2015 Jan; 2: 1–34. doi: 10.1111/ajt.13195.Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Stewart DE et al. OPTN/SRTR 2013 Annual data report: Kidney. Am J Transplant. 2015 Jan; 2: 1–34. doi: 10.1111/ajt.13195.Ploussard G, Chambade D, Meria P, Gaudez F, Tariel E, Verine J et al. Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort. BJU Int. 2012 Jan; 109 (2): 195–199. doi: 10.1111/j.1464410X.2011.10315.x. Epub 2011 Aug 2. PMID: 21810160.Ploussard G, Chambade D, Meria P, Gaudez F, Tariel E, Verine J et al. Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort. BJU Int. 2012 Jan; 109 (2): 195–199. doi: 10.1111/j.1464410X.2011.10315.x. Epub 2011 Aug 2. PMID: 21810160.Chewcharat A, Thongprayoon C, Bathini T, Aeddula NR, Boonpheng B, Kaewput W et al. Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis. J Clin Med. 2019 Apr 17; 8 (4): 530. doi: 10.3390/jcm8040530. PMID: 30999706.Chewcharat A, Thongprayoon C, Bathini T, Aeddula NR, Boonpheng B, Kaewput W et al. Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis. J Clin Med. 2019 Apr 17; 8 (4): 530. doi: 10.3390/jcm8040530. PMID: 30999706.Favi E, Raison N, Ambrogi F, Delbue S, Clementi MC, Lamperti L et al. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. World J Clin Cases. 2019 Sep 6; 7 (17): 2487–2504. doi: 10.12998/wjcc.v7.i17.2487. PMID: 31559284.Favi E, Raison N, Ambrogi F, Delbue S, Clementi MC, Lamperti L et al. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. World J Clin Cases. 2019 Sep 6; 7 (17): 2487–2504. doi: 10.12998/wjcc.v7.i17.2487. PMID: 31559284.Клинические рекомендации. Рак паренхимы почки – 2021–2022–2023. Министерство здравоохранения Российской Федерации. Clinical recommendations. Cancer of the kidney parenchyma – 2021–2022–2023. Ministry of Health of the Russian Federation. Available from: https://oncology-association.ru/wp-content/uploads/2023/11/rak-pochki_23.pdf?ysclid=lwuz3mnez3384504166.Клинические рекомендации. Рак паренхимы почки – 2021–2022–2023. Министерство здравоохранения Российской Федерации. Clinical recommendations. Cancer of the kidney parenchyma – 2021–2022–2023. Ministry of Health of the Russian Federation. Available from: https://oncology-association.ru/wp-content/uploads/2023/11/rak-pochki_23.pdf?ysclid=lwuz3mnez3384504166.Griffith JJ, Amin KA, Waingankar N, Lerner SM, Delaney V, Ames SA et al. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management. Am J Transplant. 2017 Nov; 17 (11): 2775–2781. doi: 10.1111/ajt.14366. Epub 2017 Jun 27. PMID: 28544435.Griffith JJ, Amin KA, Waingankar N, Lerner SM, Delaney V, Ames SA et al. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management. Am J Transplant. 2017 Nov; 17 (11): 2775–2781. doi: 10.1111/ajt.14366. Epub 2017 Jun 27. PMID: 28544435.Yeh CC, Khan A, Muo CH, Yang HR, Li PC, Chang CH et al. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan. Exp Clin Transplant. 2020 Apr; 18 (2): 224–233. doi: 10.6002/ect.2019.0210. Epub 2020 Mar 4. PMID: 32133940.Yeh CC, Khan A, Muo CH, Yang HR, Li PC, Chang CH et al. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan. Exp Clin Transplant. 2020 Apr; 18 (2): 224–233. doi: 10.6002/ect.2019.0210. Epub 2020 Mar 4. PMID: 32133940.Crocerossa F, Autorino R, Derweesh I, Carbonara U, Cantiello F, Damiano R et al. Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis. Minerva Urol Nephrol. 2023 Feb; 75 (1): 1–16. doi: 10.23736/S2724-6051.22.04881-9. Epub 2022 Sep 12. PMID: 36094386.Crocerossa F, Autorino R, Derweesh I, Carbonara U, Cantiello F, Damiano R et al. Management of renal cell carcinoma in transplant kidney: a systematic review and meta-analysis. Minerva Urol Nephrol. 2023 Feb; 75 (1): 1–16. doi: 10.23736/S2724-6051.22.04881-9. Epub 2022 Sep 12. PMID: 36094386.Lentine KL, Smith JM, Hart A, Miller J, Skeans MA, Larkin L et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant. 2022 Mar; 22 (2): 21–136. doi: 10.1111/ajt.16982. PMID: 35266618.Lentine KL, Smith JM, Hart A, Miller J, Skeans MA, Larkin L et al. OPTN/SRTR 2020 Annual Data Report: Kidney. Am J Transplant. 2022 Mar; 22 (2): 21–136. doi: 10.1111/ajt.16982. PMID: 35266618.Ogawa Y, Kojima K, Mannami R, Mannami M, Kitajima K, Nishi M et al. Transplantation of Restored Kidneys From Unrelated Donors After Resection of Renal Cell Carcinoma: Results From 10 Patients. Transplant Proc. 2015 Jul-Aug; 47 (6): 1711–1719. doi: 10.1016/j.transproceed.2015.06.030. PMID: 26293039.Ogawa Y, Kojima K, Mannami R, Mannami M, Kitajima K, Nishi M et al. Transplantation of Restored Kidneys From Unrelated Donors After Resection of Renal Cell Carcinoma: Results From 10 Patients. Transplant Proc. 2015 Jul-Aug; 47 (6): 1711–1719. doi: 10.1016/j.transproceed.2015.06.030. PMID: 26293039.Sultan S, Finn C, Craig-Schapiro R, Aull M, Watkins A, Kapur S et al. Simultaneous Living Donor Kidney Transplant and Laparoscopic Native Nephrectomy: An Approach to Kidney Transplant Candidates with Suspected Renal-Cell Carcinoma. J Endourol. 2021 Jul; 35 (7): 1001–1005. doi: 10.1089/end.2020.0841. Epub 2020 Dec 31. PMID: 33238756.Sultan S, Finn C, Craig-Schapiro R, Aull M, Watkins A, Kapur S et al. Simultaneous Living Donor Kidney Transplant and Laparoscopic Native Nephrectomy: An Approach to Kidney Transplant Candidates with Suspected Renal-Cell Carcinoma. J Endourol. 2021 Jul; 35 (7): 1001–1005. doi: 10.1089/end.2020.0841. Epub 2020 Dec 31. PMID: 33238756.Ambrosi F, Ricci C, Malvi D, De Cillia C, Ravaioli M, Fiorentino M et al. Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. Kidney Res Clin Pract. 2020 Dec 31; 39 (4): 487–494. doi: 10.23876/j.krcp.20.050. PMID: 32855366.Ambrosi F, Ricci C, Malvi D, De Cillia C, Ravaioli M, Fiorentino M et al. Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. Kidney Res Clin Pract. 2020 Dec 31; 39 (4): 487–494. doi: 10.23876/j.krcp.20.050. PMID: 32855366.Musquera M, Sierra A, Diekmann F, Perez M, Mercader C, Peri L et al. Increasing kidney grafts for transplantation. World J Urol. 2021 Jul; 39 (7): 2795–2800. doi: 10.1007/s00345-020-03463-x. Epub 2020 Sep 30. PMID: 33000340.Musquera M, Sierra A, Diekmann F, Perez M, Mercader C, Peri L et al. Increasing kidney grafts for transplantation. World J Urol. 2021 Jul; 39 (7): 2795–2800. doi: 10.1007/s00345-020-03463-x. Epub 2020 Sep 30. PMID: 33000340.Eggers H, Güler F, Ehlers U, Ivanyi P, Peters I, Grünwald V. Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center. Future Oncol. 2019 Nov; 15 (32): 3739–3750. doi: 10.2217/fon-2019-0397. Epub 2019 Oct 30. PMID: 31664864.Eggers H, Güler F, Ehlers U, Ivanyi P, Peters I, Grünwald V. Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center. Future Oncol. 2019 Nov; 15 (32): 3739–3750. doi: 10.2217/fon-2019-0397. Epub 2019 Oct 30. PMID: 31664864.Warren H, Olsburgh J. Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft. Curr Urol Rep. 2020 Feb 11; 21 (1): 8. doi: 10.1007/s11934020-0959-4. PMID: 32048068.Warren H, Olsburgh J. Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft. Curr Urol Rep. 2020 Feb 11; 21 (1): 8. doi: 10.1007/s11934020-0959-4. PMID: 32048068.Frohlich FA, Halleck F, Lehner L, Schrezenmeier EV, Naik M, Schmidt D et al. De-novo malignancies after kidney transplantation: A long-term observational study. PLoS One. 2020 Nov 30; 15 (11): e0242805. doi: 10.1371/journal.pone.0242805. PMID: 33253202.Frohlich FA, Halleck F, Lehner L, Schrezenmeier EV, Naik M, Schmidt D et al. De-novo malignancies after kidney transplantation: A long-term observational study. PLoS One. 2020 Nov 30; 15 (11): e0242805. doi: 10.1371/journal.pone.0242805. PMID: 33253202.Nabi Z, Zahid T, Nabi R. Post Renal Transplant Malignancies: A Basic Concept. J Ayub Med Coll Abbottabad. 2023 Oct-Dec; 35 (4): 664–668. doi: 10.55519/JAMC04-12230. PMID: 38406957.Nabi Z, Zahid T, Nabi R. Post Renal Transplant Malignancies: A Basic Concept. J Ayub Med Coll Abbottabad. 2023 Oct-Dec; 35 (4): 664–668. doi: 10.55519/JAMC04-12230. PMID: 38406957.Crespo E, Fernandez L, Lucia M, Melilli E, Lauzurica R, Penin RM et al. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients. Transplantation. 2017 Sep; 101 (9): 2102–2110. doi: 10.1097/TP.0000000000001759. PMID: 28403126.Crespo E, Fernandez L, Lucia M, Melilli E, Lauzurica R, Penin RM et al. Effector Antitumor and Regulatory T Cell Responses Influence the Development of Nonmelanoma Skin Cancer in Kidney Transplant Patients. Transplantation. 2017 Sep; 101 (9): 2102–2110. doi: 10.1097/TP.0000000000001759. PMID: 28403126.Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005 Oct 15; 80 (2): 254– 264. doi: 10.1097/01.tp.0000186382.81130.ba. PMID: 16251858.Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005 Oct 15; 80 (2): 254– 264. doi: 10.1097/01.tp.0000186382.81130.ba. PMID: 16251858.Krisl JC, Doan VP. Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients. Am J Transplant. 2017 Aug; 17 (8): 1974–1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10. PMID: 28394486.Krisl JC, Doan VP. Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients. Am J Transplant. 2017 Aug; 17 (8): 1974–1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10. PMID: 28394486.Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016 Jan; 16 (1): 7–19. doi: 10.1038/nrc.2015.5. PMID: 26694935.Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016 Jan; 16 (1): 7–19. doi: 10.1038/nrc.2015.5. PMID: 26694935.Billups K, Neal J, Salyer J. Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant. 2015 Jun; 25 (2): 182–188. doi: 10.7182/pit2015826. PMID: 26107280.Billups K, Neal J, Salyer J. Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant. 2015 Jun; 25 (2): 182–188. doi: 10.7182/pit2015826. PMID: 26107280.Wang K, Xu X, Fan M. Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis. Clin Exp Nephrol. 2018 Jun; 22 (3): 684–693. doi: 10.1007/s10157-017-1480-z. Epub 2017 Oct 6. PMID: 28986715.Wang K, Xu X, Fan M. Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis. Clin Exp Nephrol. 2018 Jun; 22 (3): 684–693. doi: 10.1007/s10157-017-1480-z. Epub 2017 Oct 6. PMID: 28986715.Maluccio M, Sharma V, Lagman M, Vyas S, Yang H, Li B et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation. 2003 Aug 15; 76 (3): 597–602. doi: 10.1097/01.TP.0000081399.75231.3B. PMID: 12923450.Maluccio M, Sharma V, Lagman M, Vyas S, Yang H, Li B et al. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation. 2003 Aug 15; 76 (3): 597–602. doi: 10.1097/01.TP.0000081399.75231.3B. PMID: 12923450.Engels EA, Jennings L, Kemp TJ, Chaturvedi AK, Pinto LA, Pfeiffer RM et al. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients. Cancer Med. 2015 Aug; 4 (8): 1252–1257. doi: 10.1002/cam4.455. Epub 2015 Apr 27. PMID: 25919050.Engels EA, Jennings L, Kemp TJ, Chaturvedi AK, Pinto LA, Pfeiffer RM et al. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients. Cancer Med. 2015 Aug; 4 (8): 1252–1257. doi: 10.1002/cam4.455. Epub 2015 Apr 27. PMID: 25919050.Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomized comparison of two cyclosporin regimens. Lancet. 1998 Feb 28; 351 (9103): 623–628. doi: 10.1016/S0140-6736(97)08496-1. PMID: 9500317.Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomized comparison of two cyclosporin regimens. Lancet. 1998 Feb 28; 351 (9103): 623–628. doi: 10.1016/S0140-6736(97)08496-1. PMID: 9500317.Ghidini M, Petrelli F, Ghidini A, Tomasello G, Hahne JC, Passalacqua R et al. Clinical development of mTor inhibitors for renal cancer. Expert Opin Investig Drugs. 2017 Nov; 26 (11): 1229–1237. doi: 10.1080/13543784.2017.1384813. Epub 2017 Oct 3. PMID: 28952411.Ghidini M, Petrelli F, Ghidini A, Tomasello G, Hahne JC, Passalacqua R et al. Clinical development of mTor inhibitors for renal cancer. Expert Opin Investig Drugs. 2017 Nov; 26 (11): 1229–1237. doi: 10.1080/13543784.2017.1384813. Epub 2017 Oct 3. PMID: 28952411.Hall EC, Engels EA, Pfeiffer RM, Segev DL. Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation. 2015 May; 99 (5): 1051–1057. doi: 10.1097/TP.0000000000000449. PMID: 25340595.Hall EC, Engels EA, Pfeiffer RM, Segev DL. Association of antibody induction immunosuppression with cancer after kidney transplantation. Transplantation. 2015 May; 99 (5): 1051–1057. doi: 10.1097/TP.0000000000000449. PMID: 25340595.Stucker F, Marti HP, Hunger RE. Immunosuppressive drugs in organ transplant recipients-rationale for critical selection. Curr Probl Dermatol. 2012; 43: 36–48. doi: 10.1159/000335148. Epub 2012 Feb 17. PMID: 22377918.Stucker F, Marti HP, Hunger RE. Immunosuppressive drugs in organ transplant recipients-rationale for critical selection. Curr Probl Dermatol. 2012; 43: 36–48. doi: 10.1159/000335148. Epub 2012 Feb 17. PMID: 22377918.Campistol JM, Cuervas-Mons V, Manito N, Almenar L, Arias M, Casafont F et al. New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando). 2012 Oct; 26 (4): 261– 279. doi: 10.1016/j.trre.2012.07.001. Epub 2012 Aug 15. PMID: 22902168.Campistol JM, Cuervas-Mons V, Manito N, Almenar L, Arias M, Casafont F et al. New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando). 2012 Oct; 26 (4): 261– 279. doi: 10.1016/j.trre.2012.07.001. Epub 2012 Aug 15. PMID: 22902168.Nguyen LS, Vautier M, Allenbach Y, Zahr N, Benveniste O, Funck-Brentano C et al. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Saf. 2019 Jul; 42 (7): 813–825. doi: 10.1007/s40264-019-00810-9. PMID: 30868436.Nguyen LS, Vautier M, Allenbach Y, Zahr N, Benveniste O, Funck-Brentano C et al. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Saf. 2019 Jul; 42 (7): 813–825. doi: 10.1007/s40264-019-00810-9. PMID: 30868436.Populo H, Lopes JM, Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci. 2012; 13 (2): 1886–1918. doi: 10.3390/ijms13021886. Epub 2012 Feb 10. PMID: 22408430.Populo H, Lopes JM, Soares P. The mTOR signalling pathway in human cancer. Int J Mol Sci. 2012; 13 (2): 1886–1918. doi: 10.3390/ijms13021886. Epub 2012 Feb 10. PMID: 22408430.Lamberti G, Brighi N, Maggio I, Manuzzi L, Peterle C, Ambrosini V et al. The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? Int J Mol Sci. 2018 Mar 6; 19 (3): 747. doi: 10.3390/ijms19030747. PMID: 29509701.Lamberti G, Brighi N, Maggio I, Manuzzi L, Peterle C, Ambrosini V et al. The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? Int J Mol Sci. 2018 Mar 6; 19 (3): 747. doi: 10.3390/ijms19030747. PMID: 29509701.Au EH, Chapman JR, Craig JC, Lim WH, Teixeira-Pinto A, Ullah S et al. Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant. J Am Soc Nephrol. 2019 Mar; 30 (3): 471–480. doi: 10.1681/ASN.2018090906. Epub 2019 Feb 14. PMID: 30765426.Au EH, Chapman JR, Craig JC, Lim WH, Teixeira-Pinto A, Ullah S et al. Overall and site-specific cancer mortality in patients on dialysis and after kidney transplant. J Am Soc Nephrol. 2019 Mar; 30 (3): 471–480. doi: 10.1681/ASN.2018090906. Epub 2019 Feb 14. PMID: 30765426.Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B et al. Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort. Transplantation. 2018 May; 102 (5): 860–867. doi: 10.1097/TP.0000000000002009. PMID: 29215458.Cognard N, Anglicheau D, Gatault P, Girerd S, Essig M, Hurault de Ligny B et al. Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort. Transplantation. 2018 May; 102 (5): 860–867. doi: 10.1097/TP.0000000000002009. PMID: 29215458.Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017 Mar 9; 3: 17009. doi: 10.1038/nrdp.2017.9. PMID: 28276433.Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017 Mar 9; 3: 17009. doi: 10.1038/nrdp.2017.9. PMID: 28276433.Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022 Jun 20; 39 (3): 20–22. PMID: 35819037.Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022 Jun 20; 39 (3): 20–22. PMID: 35819037.Tillou X, Doerfler A, Collon S, Kleinclauss F, Patard JJ, Badet L et al. De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant. 2012 Dec; 12 (12): 3308–3315. doi: 10.1111/j.1600-6143.2012.04248.x. Epub 2012 Sep 7. PMID: 22959020.Tillou X, Doerfler A, Collon S, Kleinclauss F, Patard JJ, Badet L et al. De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant. 2012 Dec; 12 (12): 3308–3315. doi: 10.1111/j.1600-6143.2012.04248.x. Epub 2012 Sep 7. PMID: 22959020.Billis A, Freitas LL, Costa LB, Barreto IS, Asato MA, Araujo KS et al. Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types. Transplant Proc. 2017 Oct; 49 (8): 1783– 1785. doi: 10.1016/j.transproceed.2017.06.035. PMID: 28923625.Billis A, Freitas LL, Costa LB, Barreto IS, Asato MA, Araujo KS et al. Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types. Transplant Proc. 2017 Oct; 49 (8): 1783– 1785. doi: 10.1016/j.transproceed.2017.06.035. PMID: 28923625.Hubatsch M, Peters R, Maxeiner A, El-Bandar N, Weinberger S, Friedersdorff F. Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature. Urol Int. 2020; 104 (11–12): 997–999. doi: 10.1159/000509292. Epub 2020 Sep 23. PMID: 32966984.Hubatsch M, Peters R, Maxeiner A, El-Bandar N, Weinberger S, Friedersdorff F. Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature. Urol Int. 2020; 104 (11–12): 997–999. doi: 10.1159/000509292. Epub 2020 Sep 23. PMID: 32966984.Song Y, Zheng J, Guo S, Fan L. An intracapsular nephrectomy for the acquired cystic disease-associated renal cell carcinoma in renal transplant allograft: A clinical case report. Medicine (Baltimore). 2021 May 14; 100 (19): 258. doi: 10.1097/MD.0000000000025858. PMID: 34106631.Song Y, Zheng J, Guo S, Fan L. An intracapsular nephrectomy for the acquired cystic disease-associated renal cell carcinoma in renal transplant allograft: A clinical case report. Medicine (Baltimore). 2021 May 14; 100 (19): 258. doi: 10.1097/MD.0000000000025858. PMID: 34106631.Saparbay J, Assykbayev M, Abdugafarov S. Chromophobe Renal Cell Carcinoma of a Renal Allograft. Am J Case Rep. 2021 Oct 8; 22: 933168. doi: 10.12659/AJCR.933168. PMID: 34620815.Saparbay J, Assykbayev M, Abdugafarov S. Chromophobe Renal Cell Carcinoma of a Renal Allograft. Am J Case Rep. 2021 Oct 8; 22: 933168. doi: 10.12659/AJCR.933168. PMID: 34620815.Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E et al. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight. 2017 Jun 15; 2 (12): e92688. doi: 10.1172/jci.insight.92688. PMID: 28614790.Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E et al. Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma. JCI Insight. 2017 Jun 15; 2 (12): e92688. doi: 10.1172/jci.insight.92688. PMID: 28614790.Zahran MH, Soltan MA, Kamal AI, Abdelrahim M, Fakhreldin I, Osman Y et al. De novo chromophobe renal cell carcinoma in the graft three decades after renal transplantation in a patient with a history of three renal transplants. Saudi J Kidney Dis Transpl. 2020 JanFeb; 31 (1): 271–275. doi: 10.4103/1319-2442.279952. PMID: 32129224.Zahran MH, Soltan MA, Kamal AI, Abdelrahim M, Fakhreldin I, Osman Y et al. De novo chromophobe renal cell carcinoma in the graft three decades after renal transplantation in a patient with a history of three renal transplants. Saudi J Kidney Dis Transpl. 2020 JanFeb; 31 (1): 271–275. doi: 10.4103/1319-2442.279952. PMID: 32129224.Dincer E, Ipek OM, Kayipmaz SS, Akca O. Solid Renal Mass in a Transplanted Allograft Kidney: Mucinous Tubular and Spindle Cell Renal Cell Carcinoma. J Coll Physicians Surg Pak. 2022 Aug; 32 (8): 192–194. doi: 10.29271/jcpsp.2022.Supp2.S192. PMID: 36210692.Dincer E, Ipek OM, Kayipmaz SS, Akca O. Solid Renal Mass in a Transplanted Allograft Kidney: Mucinous Tubular and Spindle Cell Renal Cell Carcinoma. J Coll Physicians Surg Pak. 2022 Aug; 32 (8): 192–194. doi: 10.29271/jcpsp.2022.Supp2.S192. PMID: 36210692.Pagano D, Francesco F, Rosa L, Nwaiwu CA, Petri SL, Gruttadauria S. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report. World J Surg Oncol. 2018 Jul 2; 16 (1): 123. doi: 10.1186/s12957-018-1426-2. PMID: 29966524.Pagano D, Francesco F, Rosa L, Nwaiwu CA, Petri SL, Gruttadauria S. Oncocytoma managed by active surveillance in a transplant allograft kidney: a case report. World J Surg Oncol. 2018 Jul 2; 16 (1): 123. doi: 10.1186/s12957-018-1426-2. PMID: 29966524.Kim CS, Choi SJ, Kim SS, Suh SH, Bae EH, Ma SK et al. An anastomosing hemangioma mimicking a renal cell carcinoma in a kidney transplant recipient: a case report. BMC Nephrol. 2021 Jul 13; 22 (1): 262. doi: 10.1186/s12882-021-02467-y. PMID: 34256731.Kim CS, Choi SJ, Kim SS, Suh SH, Bae EH, Ma SK et al. An anastomosing hemangioma mimicking a renal cell carcinoma in a kidney transplant recipient: a case report. BMC Nephrol. 2021 Jul 13; 22 (1): 262. doi: 10.1186/s12882-021-02467-y. PMID: 34256731.Rotman S, Deruaz C, Venetz JP, Chaubert P, Benhattar J, Meuwly JY et al. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin. Hum Pathol. 2006 Apr; 37 (4): 481–487. doi: 10.1016/j.humpath.2005.11.024. PMID: 16564925.Rotman S, Deruaz C, Venetz JP, Chaubert P, Benhattar J, Meuwly JY et al. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin. Hum Pathol. 2006 Apr; 37 (4): 481–487. doi: 10.1016/j.humpath.2005.11.024. PMID: 16564925.Boix R, Sanz C, Mora M, Quer A, Beyer K, Musulen E et al. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin. Transplantation. 2009 Apr 15; 87 (7): 1057–1061. doi: 10.1097/TP.0b013e31819d1e5f. PMID: 19352128.Boix R, Sanz C, Mora M, Quer A, Beyer K, Musulen E et al. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin. Transplantation. 2009 Apr 15; 87 (7): 1057–1061. doi: 10.1097/TP.0b013e31819d1e5f. PMID: 19352128.Paradis V, Dargere D, Bonvoust F, Rubbia-Brandt L, Ba N, Bioulac-Sage P et al. Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest. 2000 Oct; 80 (10): 1553–1559. doi: 10.1038/labinvest.3780165. PMID: 11045572.Paradis V, Dargere D, Bonvoust F, Rubbia-Brandt L, Ba N, Bioulac-Sage P et al. Clonal analysis of micronodules in virus C-induced liver cirrhosis using laser capture microdissection (LCM) and HUMARA assay. Lab Invest. 2000 Oct; 80 (10): 1553–1559. doi: 10.1038/labinvest.3780165. PMID: 11045572.Исаев ТК. Почечно-клеточный рак трансплантированной почки: дис. … докт. мед. наук. М., 2023; 162 с.Isaev TK. Renal cell carcinoma of the transplanted kidney. [Dissertation]. М., 2023; 162.Tillou X, Guleryuz K, Collon S, Doerfler A. Renal cell carcinoma in functional renal graft: Toward ablative treatments. Transplant Rev (Orlando). 2016 Jan; 30 (1): 20–26. doi: 10.1016/j.trre.2015.07.001. PMID: 26318289.Tillou X, Guleryuz K, Collon S, Doerfler A. Renal cell carcinoma in functional renal graft: Toward ablative treatments. Transplant Rev (Orlando). 2016 Jan; 30 (1): 20–26. doi: 10.1016/j.trre.2015.07.001. PMID: 26318289.Vasisth G, Kapoor A, Piercey K, Lambe S. Renal cell carcinoma in renal allograft: Case series and review of literature. Urol Ann. 2018 Apr-Jun; 10 (2): 229–232. doi: 10.4103/UA.UA_66_17. PMID: 29719341.Vasisth G, Kapoor A, Piercey K, Lambe S. Renal cell carcinoma in renal allograft: Case series and review of literature. Urol Ann. 2018 Apr-Jun; 10 (2): 229–232. doi: 10.4103/UA.UA_66_17. PMID: 29719341.

The authors declare that there are no conflicts of interest present.